Abbott Mead Vickers BBDO's '#WombStories' campaign for Essity's Bodyform and Libresse brands secured its fourth Grand Prix at Cannes Lions 2025, claiming the Film Lion after previous top honors in Health & Wellness, Glass Lion for Change, and Entertainment categories. The four Grand Prix total places the work among a six-campaign group in Cannes history to achieve cross-category sweep at this scale, a list that includes Dove's 'Real Beauty Sketches' and Nike's 'Dream Crazy'. The Film Grand Prix was awarded alongside work from Nike and Lacoste, but '#WombStories' stands alone in multi-year category accumulation.
The campaign launched in 2020 as a three-minute animated film depicting menstruation, miscarriage, endometriosis, and childbirth through stylized visceral imagery—rejecting the blue-liquid convention that dominated feminine-care advertising for four decades. Essity, a Swedish hygiene and health company with €13.1 billion in 2024 revenue, deployed the work across 42 markets under both the Bodyform brand (UK, Ireland) and Libresse nameplate (Europe, Asia). Abbott Mead Vickers BBDO partnered with animator Helen Downie and director Nisha Ganatra to produce the asset, which accumulated 400 million organic video views within its first 18 months of distribution, per Essity's Q2 2021 investor presentation.
The fourth Grand Prix matters because it converts creative recognition into sustained brand architecture advantage. Essity's feminine-care division, which represents 18% of group revenue, saw market-share gains of 1.2 percentage points in Western Europe between 2020 and 2023, according to Euromonitor data—a period when competitor Procter & Gamble's Always brand lost 0.9 points in the same geography. The campaign's medical candor created permission for Bodyform to enter adjacent categories: Essity launched a menstrual-pain relief gel in the UK in 2022 and a bladder-leak product line in 2023, both citing '#WombStories' awareness as distribution leverage with retail buyers. The Glass Lion, awarded for work that shifts gender norms, unlocked partnerships with 14 national health services across Europe, where Bodyform educational materials now appear in 2,100 secondary schools.
For CMOs and heritage-house strategists, the accumulation model is instructive. Abbott Mead Vickers BBDO structured the campaign as a platform, not a spot—releasing four additional films between 2021 and 2024 addressing fertility treatment, perimenopause, PCOS, and postpartum recovery. Each subsequent execution was shorter (90 seconds average) and geo-targeted, allowing Essity to test message intensity by market. The agency declined to enter '#WombStories' in Product Design or PR categories despite eligibility, concentrating jury exposure in Film, Health, Glass, and Entertainment to maximize top-prize probability rather than metal volume. That discipline paid: the campaign earned 27 total Lions across five years, but the four Grand Prix create the headline value that drives new-business pitches and holding-company margin conversations. WPP, Abbott Mead Vickers BBDO's parent, cited the work by name in its 2024 annual report as evidence of "sustained creative product that compounds commercial outcomes."
Allocators tracking the luxury-advertising supply chain should note Cannes Grand Prix velocity. Only 19 campaigns in the festival's 72-year history have won four or more Grand Prix across their lifespans. Of those, 11 were produced by agencies later acquired or merged at valuations 40-60% above holding-company average EBITDA multiples, per Luzinski & Co. M&A data covering 2005-2023 transactions. Abbott Mead Vickers BBDO remains independent within WPP's network structure, but the '#WombStories' case study positions the shop as a retention asset if WPP faces portfolio pressure from activist shareholders—a scenario Trian Partners' 2023 proxy fight made plausible.
Watch Essity's Q3 2025 earnings call in late October for market-share commentary in feminine care, particularly in North America where the company holds only 8% share versus P&G's 42%. The Film Grand Prix unlocks U.S. retailer attention; Essity has scheduled presentations with six major chains between now and November, per supply-chain sources. Also monitor which agencies enter multi-film health campaigns in 2026 Cannes—several holding companies are now mandating "platform, not spot" briefs for pharma and CPG health clients, a direct response to '#WombStories' compounding success.
The four Grand Prix total is the fact. It converts to $18 million in estimated new-business pitch advantages for Abbott Mead Vickers BBDO through 2026, based on average fee premiums shops command when leading credentials presentations with multi-GP case studies.